Overview
Jithin Yohannan, M.D., M.P.H. is Boone Pickens Rising Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. His practice specializes in medical, laser, and surgical treatment of glaucoma, focusing on minimally invasive glaucoma surgery (MIGS) and new glaucoma surgical devices. He also performs both routine and complex cataract surgery. Dr. Yohannan also specializes in the surgical management of complex problems of the anterior segment (front of the eye). These problems include issues arising after trauma or prior surgery gone wrong, such as dislocated intraocular lenses (IOL) or iris and pupil defects. Dr. Yohannan earned his bachelor’s degree in biochemistry from New York University, where he graduated summa cum laude. He then received his medical and master of public health degrees from Johns Hopkins University. He completed an ophthalmology residency at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. From there, he served as a fellow in glaucoma and advanced anterior segment surgery at the University of Toronto. Dr. Yohannan then returned to Wilmer to serve as Assistant Chief of Service for one year, after which he joined the glaucoma division. Dr. Yohannan holds a joint appointment at the Malone Center of Engineering in Healthcare. He leads a lab that focuses on using artificial intelligence algorithms to aid in the diagnosis and management of glaucoma patients. He has a background in biostatistics, epidemiology, and mathematics, which enables this effort. His group has developed AI models that forecast high-risk glaucoma patients and is focused on translating these models for clinical application. Additionally, his group aims to understand how we can optimize structural and functional glaucoma testing to improve the detection of glaucoma worsening. Dr. Yohannan also has a clinical and research interest in novel surgical devices used to treat glaucoma. These devices promise to make glaucoma surgery safer and easier to recover from. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Yohannan_Jithin_CV.pdf Lab Website Wilmer Glaucoma ML - Lab Website Research Summary Dr. Yohannan research focuses on using artificial intelligence algorithms to improve the tests that we use to diagnose and monitor glaucoma. He has a background in biostatistics, epidemiology, and mathematics which enables this effort. The ultimate goal of this research is to detect glaucoma and determine when it is worsening more accurately. The results of this work will ultimately help guide doctors who are managing glaucoma to make better treatment decisions. Dr. Yohannan also has a clinical and research interest in novel surgical devices used to treat glaucoma. These devices hold the promise of making glaucoma surgery safer and easier to recover from.
Dr. Yohannan is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.
Dr. Yohannan is board certified in American Board Of Ophthalmology. He is actively involved in clinical research, co-authoring 55 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Belcamp, MD 21017
10710 Charter Drive, Suite 310, Columbia, MD 21044
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy. Dr. Campochiaro is board certified in American Board Of Ophthalmology.
Office
Janet Sunness is an Ophthalmologist practicing medicine in Towson, Maryland. Dr. Sunness is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Stargardt Macular Degeneration, Geographic Atrophy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).
Brian Brooks is an Ophthalmologist practicing medicine in Washington, Washington, D.c.. Dr. Brooks is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Coloboma, Albinism, Oculocutaneous Albinism Type 2, and Oculocutaneous Albinism Type 1.
Frequently Asked Questions about Dr. Jithin Yohannan
How do I make an appointment with Dr. Jithin Yohannan?
You can book an appointment with Dr. Jithin Yohannan by calling their office at 410-836-7010. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jithin Yohannan a top-rated expert for Glaucoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jithin Yohannan is classified as an Elite expert for Glaucoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jithin Yohannan specialize in?
While Dr. Jithin Yohannan is a Ophthalmology, they have specific expertise in Glaucoma, Ocular Hypertension (OHT), and Pigment-Dispersion Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Jithin Yohannan participate in research or clinical trials?
Yes. Dr. Jithin Yohannan has published 55 articles and abstracts on conditions like Glaucoma. You can view a list of Dr. Jithin Yohannan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jithin Yohannan accept my insurance?
Dr. Jithin Yohannan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-836-7010 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- GlaucomaDr. Yohannan isElite. Learn about Glaucoma.
- Distinguished
- Ocular Hypertension (OHT)Dr. Yohannan isDistinguished. Learn about Ocular Hypertension (OHT).
- Advanced
- CataractDr. Yohannan isAdvanced. Learn about Cataract.
- Pigment-Dispersion SyndromeDr. Yohannan isAdvanced. Learn about Pigment-Dispersion Syndrome.
- TrabeculectomyDr. Yohannan isAdvanced. Learn about Trabeculectomy.
- Experienced
- Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE)
- Cataract RemovalDr. Yohannan isExperienced. Learn about Cataract Removal.
- Conjunctivitis (Pink Eye)Dr. Yohannan isExperienced. Learn about Conjunctivitis (Pink Eye).
- DRESS SyndromeDr. Yohannan isExperienced. Learn about DRESS Syndrome.
- Gyrate Atrophy of the Choroid and RetinaDr. Yohannan isExperienced. Learn about Gyrate Atrophy of the Choroid and Retina.